<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>B-cell non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) has been well described in association with human <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> virus (HIV) and the acquired <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> syndrome (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Many of these <z:hpo ids='HP_0002665'>lymphomas</z:hpo> are of the diffuse, aggressive, subtype B-cell NHL, including Burkitt and Burkitt-like <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Recently, there have been reports of B-cell <z:hpo ids='HP_0011009'>acute</z:hpo> lymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (ALL), Burkitt type, in patients who were either HIV antibody-positive or at high risk for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>We have seen three cases of B-cell ALL, Burkitt type, and herein describe their clinical and laboratory characteristics </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients were HIV antibody-positive </plain></SENT>
<SENT sid="5" pm="."><plain>Since stage IV Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in blood phase and B-cell ALL, Burkitt type, represent a continuum of the same disease, and since it is also an aggressive B-cell <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e>, we suggest that B-cell ALL, Burkitt type, in HIV antibody-positive patients should support the diagnosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> </plain></SENT>
</text></document>